Progression of atherosclerosis with carnitine supplementation: a randomized controlled trial in the metabolic syndrome
Abstract Background L-carnitine (L-C), a ubiquitous nutritional supplement, has been investigated as a potential therapy for cardiovascular disease, but its effects on human atherosclerosis are unknown. Clinical studies suggest improvement of some cardiovascular risk factors, whereas others show inc...
Main Authors: | Amer M. Johri, Marie-France Hétu, Daren K. Heyland, Julia E. Herr, Jennifer Korol, Shawna Froese, Patrick A. Norman, Andrew G. Day, Murray F. Matangi, Erin D. Michos, Stephen A. LaHaye, Fraser W. Saunders, J. David Spence |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-04-01
|
Series: | Nutrition & Metabolism |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12986-022-00661-9 |
Similar Items
-
Carnitine Inborn Errors of Metabolism
by: Mohammed Almannai, et al.
Published: (2019-09-01) -
The Mitochondrial Carnitine Acyl-carnitine Carrier (SLC25A20): Molecular Mechanisms of Transport, Role in Redox Sensing and Interaction with Drugs
by: Annamaria Tonazzi, et al.
Published: (2021-03-01) -
Nomogram and Carotid Risk Score for Predicting Moderate or High Carotid Atherosclerosis among Asymptomatic Elderly Recycling Volunteers
by: Cheng-Lun Hsiao, et al.
Published: (2022-06-01) -
The Effects of L-Carnitine, Acetyl-L-Carnitine, and Propionyl-L-Carnitine on Body Mass in Type 2 Diabetes Mellitus Patients
by: Dong-Dong Wang, et al.
Published: (2021-11-01) -
Carotid Atherosclerosis and Cognitive Impairment in Nonstroke Patients
by: Wei-Hong Chen, et al.
Published: (2017-01-01)